SAM #FDA-RFI-27-1251190

FDA CTP seeks data discovery and AI-assisted prototype services for tobacco product submissions

The FDA’s Center for Tobacco Products is seeking market input on a 12-month effort to improve product-centric analysis of tobacco product submissions. - Government buyer: U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Tobacco Products (CTP). - OEMs and vendors: No OEMs, vendors, or specific commercial products are named in the opportunity or attachment. - Requested services: Contractor support for data discovery and baseline assessment; product definitions, lifecycle models, and cross-submission linking; AI-assisted metadata tagging and reviewer-workflow prototypes; an optional proof-of-concept demonstration; future-planning findings; transition and closeout; project management; and a final close-out report. - Key requirements: Assess submission data sources, traceability, gaps, and barriers to longitudinal product visibility; make prototype outputs traceable to source documents; document tool limitations and sample-data factors; and provide models, prototype evaluation results, integration-readiness artifacts, and knowledge-transfer materials. - Quantities and part numbers: No product purchases, quantities, or part numbers are specified. The work is described as a 12-month services effort. - Period of performance: 12 months. Kickoff is due within 10 business days of award; other deliverables follow the approved project schedule. No option periods are stated. - Opportunity context: The notice is market research for planning; it is not a commitment to award a contract.

Description

This Sources Sought Request for Information (RFI) is for information, planning and market research purposes only and shall not be construed as either a solicitation or obligation on the part of the Food and Drug Administration or its Centers. The purpose of this RFI is to help the FDA understand the technical capabilities for providing the full range of services described in the Statement of Work (SOW) attached at the end. FDA will use this market research information to assess the market's capability to successfully meet the Data Strem requirements.  FDA welcomes responses from all interested businesses. FDA does not intend to make a selection decision or award a contract on the basis of responses nor otherwise pay for the preparation of any information submitted or FDA's use of such information. Acknowledgment of receipt of responses will not be made, no questions will be answered, nor will respondents be notified of the outcome of the FDA's review of the information received. Additionally, the FDA does not intend to hold discussions concerning this RFI with any interested parties. However, FDA reserves the right to contact vendors if additional information is required. 

View original listing